Routine invasive procedures for stable heart disease found to offer no long-term survival advantage over drug therapy

AI Summary

An international study found that patients with stable heart disease and abnormal stress tests did not live longer when treated early with invasive procedures than when initially treated with medication and lifestyle changes. The findings suggest no long-term survival advantage for routine early intervention in this patient group.

Patients with stable heart disease and abnormal stress tests who have invasive procedures early in their care do not live longer than those initially treated with drugs and lifestyle changes alone, an international study shows.